Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology AGM Information 2025

Apr 9, 2025

3535_rns_2025-04-09_90524878-d53d-46c6-ab3d-ee32ddac329e.html

AGM Information

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - MINUTES FROM EXTRAORDINARY GENERAL MEETING - UPDATE ON FINANCING

AQUA BIO TECHNOLOGY ASA - MINUTES FROM EXTRAORDINARY GENERAL MEETING - UPDATE ON FINANCING

9.4.2025 13:34:13 CEST | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Aqua Bio Technology ASA ("ABTEC" or the "Company") has today, on 9 April 2025,

held an extraordinary general meeting. All resolutions were made in accordance

with the proposals of the Company's Board of Directors. The minutes of the

extraordinary general meeting are attached to this notice.

In connection with the general meeting, the Company has also received a proposal

from an investor group for a further equity investment into the Company at the

same price per share as in the private placement announced as placed on 11 March

2025. The Company's Board will review and discuss this proposal and provide

further information in due course.

DISCLOSURE REGULATION

For further information, please contact Fredrik Henriksen, CEO, Phone +47 900 20

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78,

[email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood.

The group has distribution towards B2C, B2B, B2B2, and freight, customs, and

logistics services. The group also develops sustainable biotechnology for use in

skincare products. Aqua Bio Technology is listed on the Euronext Expand market

of the Oslo Stock Exchange.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18490740/5925/Download%20announce

ment%20as%20PDF.pdf

Aqua Bio Technology ASA - Minutes of EGM 9 April 2025.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18490740/5924/Aqua%20Bio%20Techno

logy%20ASA%20-%20Minutes%20of%20EGM%209%20April%202025.pdf